Sana Biotechnology, Inc.

SANA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$103,357$71,271$96,131$127,566
Short-Term Investments$49,697$1,403$8,570$24,931
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$8,705$9,828$8,030$8,311
Total Curr. Assets$161,759$82,502$112,731$160,808
Property Plant & Equip (Net)$70,635$76,102$128,524$135,269
Goodwill$140,627$140,627$140,627$140,627
Intangibles$59,195$59,195$59,195$59,195
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$3,216$3,219$4,393$5,121
Total NC Assets$273,673$279,143$332,739$340,212
Other Assets$0$0$0$0
Total Assets$435,432$361,645$445,470$501,020
Liabilities
Payables$1,858$2,270$989$5,210
Short-Term Debt$14,768$13,832$13,003$12,534
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$18,887$17,342$19,164$27,689
Total Curr. Liab.$35,513$33,444$33,156$45,433
LT Debt$74,968$71,660$78,311$81,663
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$129,643$133,985$124,924$123,420
Total NC Liab.$204,611$205,645$203,235$205,083
Other Liabilities$0$0$0$0
Cap. Leases$89,736$85,492$91,314$94,197
Total Liabilities$240,124$239,089$236,391$250,516
Equity
Pref Stock$0$0$0$0
Common Stock$26$23$23$22
Retained Earnings-$1,790,191-$1,748,039-$1,654,239-$1,604,850
AOCI$21$0$0$14
Other Equity$1,985,452$1,870,572$1,863,295$1,855,318
Total Equity$195,308$122,556$209,079$250,504
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$435,432$361,645$445,470$501,020
Net Debt-$13,621$14,221-$4,817-$33,369